NO20050113L - Sekundaere amino-aniliniske piperidiner som MCH1-antagonister og anvendelser derav - Google Patents
Sekundaere amino-aniliniske piperidiner som MCH1-antagonister og anvendelser deravInfo
- Publication number
- NO20050113L NO20050113L NO20050113A NO20050113A NO20050113L NO 20050113 L NO20050113 L NO 20050113L NO 20050113 A NO20050113 A NO 20050113A NO 20050113 A NO20050113 A NO 20050113A NO 20050113 L NO20050113 L NO 20050113L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- subject
- provides
- treating
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18914502A | 2002-07-03 | 2002-07-03 | |
| PCT/US2003/021391 WO2004005257A1 (en) | 2002-07-03 | 2003-07-03 | Secondary amino anilinic piperidines as mch1 antagonists and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20050113L true NO20050113L (no) | 2005-01-10 |
Family
ID=30114020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20050113A NO20050113L (no) | 2002-07-03 | 2005-01-10 | Sekundaere amino-aniliniske piperidiner som MCH1-antagonister og anvendelser derav |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7473698B2 (ja) |
| EP (1) | EP1556351A4 (ja) |
| JP (1) | JP2005532399A (ja) |
| KR (1) | KR20050034710A (ja) |
| CN (1) | CN1319945C (ja) |
| AU (1) | AU2003259098A1 (ja) |
| BR (1) | BR0312257A (ja) |
| CA (1) | CA2485379A1 (ja) |
| EA (1) | EA008826B1 (ja) |
| HK (1) | HK1080471A1 (ja) |
| IL (1) | IL165730A0 (ja) |
| IS (1) | IS7560A (ja) |
| MX (1) | MXPA04012103A (ja) |
| NO (1) | NO20050113L (ja) |
| NZ (1) | NZ536329A (ja) |
| PL (1) | PL373621A1 (ja) |
| UA (1) | UA77536C2 (ja) |
| WO (1) | WO2004005257A1 (ja) |
| ZA (1) | ZA200409425B (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7105544B2 (en) | 2001-07-05 | 2006-09-12 | Synaptic Pharmaceutical Corporation | Substituted alkyl amido piperidines |
| US7199135B2 (en) | 2001-07-05 | 2007-04-03 | H. Lundbeck A/S | Substituted alkyl amido piperidines |
| US20050154020A1 (en) * | 2004-01-14 | 2005-07-14 | Synaptic Pharmaceutical Corporation | 4-Aryl piperidines |
| US20050154022A1 (en) * | 2004-01-14 | 2005-07-14 | H. Lundbeck A/S | 4-aryl piperidines |
| WO2006015279A1 (en) * | 2004-07-28 | 2006-02-09 | Neurogen Corporation | Heterocyclic diamine compounds as ligands of the melanin concentrating hormone receptor useful for the treatment of obesity, diabetes, eating and sexual disorders |
| US7446204B2 (en) | 2004-10-08 | 2008-11-04 | H. Lundbeck A/S | Amino substituted aryloxybenzylpiperidine derivatives |
| US7329656B2 (en) | 2004-10-08 | 2008-02-12 | H. Lundbeck A/S | Arylthiobenzylpiperidine derivatives |
| US20060079683A1 (en) * | 2004-10-08 | 2006-04-13 | Marzabadi Mohammad R | Arylthiobenzylpiperidine derivatives |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| SG11201807516UA (en) | 2016-03-17 | 2018-09-27 | Hoffmann La Roche | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
| FR2744448B1 (fr) | 1996-02-02 | 1998-04-24 | Pf Medicament | Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments |
| TW548271B (en) * | 1996-12-20 | 2003-08-21 | Astra Pharma Inc | Novel piperidine derivatives having an exocyclic double bond with analgesic effects |
| ES2157148B1 (es) * | 1998-11-18 | 2002-03-01 | Faes Fabrica Espanola De Produ | Nuevas piperidinas 4-sustituidas. |
| US6326381B1 (en) * | 1998-12-17 | 2001-12-04 | American Home Products Corporation | Arylpiperidine and aryl-1,2,5,6-tetrahydropyidine amide derivates |
| US20030082623A1 (en) * | 1998-12-31 | 2003-05-01 | Beth Borowsky | DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| CA2384358A1 (en) * | 2000-07-05 | 2002-01-10 | Synaptic Pharmaceutical Corporation | Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| WO2002006245A1 (en) | 2000-07-05 | 2002-01-24 | Synaptic Pharmarceutical Corporation | Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| IL158941A0 (en) | 2001-05-22 | 2004-05-12 | Neurogen Corp | Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| HUP0401880A2 (hu) | 2001-07-05 | 2005-01-28 | Synaptic Pharmaceutical Corporation | Helyettesített anilin-piperidinek mint MCH-szelektív antagonisták, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
-
2003
- 2003-03-07 UA UA20041210489A patent/UA77536C2/uk unknown
- 2003-07-03 KR KR1020057000078A patent/KR20050034710A/ko not_active Application Discontinuation
- 2003-07-03 CA CA002485379A patent/CA2485379A1/en not_active Abandoned
- 2003-07-03 NZ NZ536329A patent/NZ536329A/en unknown
- 2003-07-03 EP EP03763374A patent/EP1556351A4/en not_active Withdrawn
- 2003-07-03 AU AU2003259098A patent/AU2003259098A1/en not_active Abandoned
- 2003-07-03 MX MXPA04012103A patent/MXPA04012103A/es active IP Right Grant
- 2003-07-03 JP JP2004520047A patent/JP2005532399A/ja not_active Withdrawn
- 2003-07-03 IL IL16573003A patent/IL165730A0/xx unknown
- 2003-07-03 CN CNB038157667A patent/CN1319945C/zh not_active Expired - Fee Related
- 2003-07-03 US US10/518,675 patent/US7473698B2/en not_active Expired - Fee Related
- 2003-07-03 PL PL03373621A patent/PL373621A1/xx not_active Application Discontinuation
- 2003-07-03 WO PCT/US2003/021391 patent/WO2004005257A1/en active Application Filing
- 2003-07-03 EA EA200500152A patent/EA008826B1/ru not_active IP Right Cessation
- 2003-07-03 BR BR0312257-3A patent/BR0312257A/pt not_active IP Right Cessation
-
2004
- 2004-11-23 ZA ZA200409425A patent/ZA200409425B/en unknown
- 2004-11-26 IS IS7560A patent/IS7560A/is unknown
-
2005
- 2005-01-10 NO NO20050113A patent/NO20050113L/no not_active Application Discontinuation
-
2006
- 2006-01-09 HK HK06100334A patent/HK1080471A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL165730A0 (en) | 2006-01-15 |
| US7473698B2 (en) | 2009-01-06 |
| CA2485379A1 (en) | 2004-01-15 |
| EP1556351A4 (en) | 2007-07-25 |
| IS7560A (is) | 2004-11-26 |
| JP2005532399A (ja) | 2005-10-27 |
| BR0312257A (pt) | 2005-04-12 |
| UA77536C2 (en) | 2006-12-15 |
| EA008826B1 (ru) | 2007-08-31 |
| HK1080471A1 (en) | 2006-04-28 |
| EA200500152A1 (ru) | 2005-06-30 |
| WO2004005257A1 (en) | 2004-01-15 |
| AU2003259098A1 (en) | 2004-01-23 |
| ZA200409425B (en) | 2006-04-26 |
| KR20050034710A (ko) | 2005-04-14 |
| PL373621A1 (en) | 2005-09-05 |
| EP1556351A1 (en) | 2005-07-27 |
| NZ536329A (en) | 2007-06-29 |
| CN1319945C (zh) | 2007-06-06 |
| MXPA04012103A (es) | 2005-04-19 |
| US20050245743A1 (en) | 2005-11-03 |
| CN1665786A (zh) | 2005-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20050113L (no) | Sekundaere amino-aniliniske piperidiner som MCH1-antagonister og anvendelser derav | |
| NO20053838L (no) | Substituerte alkyl-amido-piperidiner | |
| NO20050145L (no) | Spirocykliske piperidiner som MCH1-antagonister og anvendelser derav | |
| CN110740993B (zh) | 用作钠通道调节剂的氘代吡啶酮酰胺及其前药 | |
| EA200100136A1 (ru) | Предотвращение образования слизистого секрета в дыхательных путях посредством введения антагонистов рецепторов эпидермального фактора роста (egf-r) | |
| DE60231341D1 (de) | Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten | |
| ATE450260T1 (de) | Therapeutische zusammensetzungen enthaltend 1,2,3,6-tetrahydropyrimidin-2-one und entsprechende methoden | |
| WO2002060392A3 (en) | Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods | |
| MXPA03007853A (es) | Metodo para la sintesis de 2',3'-didesoxi-2',3'-dideshidronucleosidos. | |
| NO20051048L (no) | Terapeutisk humant anti-IL-1R1 monoklonalt antistoff | |
| EA200400146A1 (ru) | Замещённые анилиновые пиперидины в качестве селективных антагонистов mch | |
| NO20081772L (no) | Ikke-basiske antagonister av melaninkonsentrerende hormon-reseptor-1 | |
| UA49796C2 (uk) | Ангідрат пароксетин гідрохлориду, спосіб його одержання, сольвати пароксетин гідрохлориду, спосіб їх одержання, спосіб лікування та/або профілактики та фармацевтична композиція | |
| NO20063650L (no) | 4-aryl-piperidiner | |
| DK1551803T3 (da) | Azabicycloderivater som muskarine receptorantagonister | |
| BR0317370A (pt) | Composição farmacêutica e método paliativo | |
| WO2000020041A3 (en) | Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent | |
| BRPI0409302A (pt) | derivados azabiciclo como antagonistas de recetores muscarìnicos, método para sua preparação e composição farmacêutica contendo os mesmos | |
| WO2001017558A3 (en) | Novel uses of mammalian ccr6 receptors and related reagents | |
| NO20080411L (no) | Alkylsulfonamiddderivater | |
| ATE342721T1 (de) | Steroide als neurochemische stimulatoren des nasenraumes zur linderung der prämenstrualen symptome | |
| WO2004080411A3 (en) | Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto | |
| WO2006041635A3 (en) | Arylthiobenzylpiperidine derivatives | |
| BRPI0413607A (pt) | composição farmacêutica para a prevenção e tratamento do vìcio em mamìferos | |
| Yunoki et al. | Role of the M 2 muscarinic receptor pathway in lidocaine-induced potentiation of the relaxant response to atrial natriuretic peptide in bovine tracheal smooth muscle |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |
|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |